Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김규보 | * |
dc.date.accessioned | 2018-11-21T16:30:45Z | - |
dc.date.available | 2018-11-21T16:30:45Z | - |
dc.date.issued | 2018 | * |
dc.identifier.issn | 0167-6806 | * |
dc.identifier.other | OAK-22113 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/246847 | - |
dc.description.abstract | Purpose: In correlation with the nodal status in the era of modern radiotherapy, the chest wall recurrence (CWR) rate was investigated in pT1-2N0-1 breast cancer patients after a mastectomy without post-mastectomy radiotherapy (PMRT). Methods: The data from the patients participating in two South Korean multi-institutional studies (KROG 14–22; N = 1842 and KROG 14–23; N = 1382) were analyzed. In total, 3224 pT1-2N0-1 breast cancer patients who underwent mastectomy without PMRT were analyzed. Results: The median follow-up time was 72.2 months (range 0.8–125.2 months). The overall CWRs during the follow-up period were 1.68% in N0 patients and 2.82% in N1 patients. There was no statistically significant difference in 5-year and 10-year CWR-free survival (CWRFS) between the N0 and N1 patients. Of the 70 patients with CWR, 33 (1% of all the patients) had isolated CWR, and the 10-year overall survival rate in this group was 96.9%. After the propensity score matching of the N0 and N1 groups, there was still no difference in CWRFS by nodal status. Conclusions: The incidence of CWR in pT1-2N0-1 breast cancer patients is very low, especially with isolated recurrence. Also, the obtained data showed that the nodal status had no impact on CWRFS. © 2018, Springer Science+Business Media, LLC, part of Springer Nature. | * |
dc.language | English | * |
dc.publisher | Springer New York LLC | * |
dc.subject | 1–3 positive nodes | * |
dc.subject | Breast cancer | * |
dc.subject | Chest wall irradiation | * |
dc.subject | Chest wall recurrence risk factor | * |
dc.subject | Post-mastectomy radiation therapy | * |
dc.title | Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy | * |
dc.type | Article | * |
dc.relation.issue | 3 | * |
dc.relation.volume | 169 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 507 | * |
dc.relation.lastpage | 512 | * |
dc.relation.journaltitle | Breast Cancer Research and Treatment | * |
dc.identifier.doi | 10.1007/s10549-018-4707-0 | * |
dc.identifier.wosid | WOS:000432317800012 | * |
dc.identifier.scopusid | 2-s2.0-85041914011 | * |
dc.author.google | Chang J.H. | * |
dc.author.google | Shin K.H. | * |
dc.author.google | Ahn S.D. | * |
dc.author.google | Park H.J. | * |
dc.author.google | Chie E.K. | * |
dc.author.google | Kim J.H. | * |
dc.author.google | Kim S.S. | * |
dc.author.google | Kim Y.B. | * |
dc.author.google | Park W. | * |
dc.author.google | Kim Y.-J. | * |
dc.author.google | Shin H.S. | * |
dc.author.google | Lee S.Y. | * |
dc.author.google | Kim K. | * |
dc.author.google | Park K.R. | * |
dc.author.google | Jeong B.K. | * |
dc.author.google | Kim J.Y. | * |
dc.author.google | Kim S. | * |
dc.contributor.scopusid | 김규보(8213302900) | * |
dc.date.modifydate | 20240222162403 | * |